MedTrace Logo

Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD

NCT00383370 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-04-21

No results posted yet for this study

Summary

To assess the safety and tolerability of repeated intravitreal (ITV) administration of VEGF Trap.

Conditions

  • Neovascular Age Related Macular Degeneration

Interventions

DRUG

VEGF Trap

VEGF Trap formulation 1, ITV-1

BIOLOGICAL

VEGF Trap

VEGF Trap formulation 2 at higher concentration in Open label cohort

Sponsors & Collaborators

Principal Investigators

  • Avner Ingerman, MD · Regeneron Pharmaceutical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2007-09-30
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00383370 on ClinicalTrials.gov